DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Shares Acquired by Crossmark Global Holdings Inc.

Crossmark Global Holdings Inc. raised its holdings in DENTSPLY SIRONA Inc. (NASDAQ:XRAYGet Rating) by 4.0% in the third quarter, Holdings Channel.com reports. The fund owned 18,007 shares of the medical instruments supplier’s stock after acquiring an additional 700 shares during the period. Crossmark Global Holdings Inc.’s holdings in DENTSPLY SIRONA were worth $510,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds also recently bought and sold shares of XRAY. Wipfli Financial Advisors LLC acquired a new stake in DENTSPLY SIRONA in the 3rd quarter valued at about $27,000. Riverview Trust Co lifted its holdings in DENTSPLY SIRONA by 185.6% in the 3rd quarter. Riverview Trust Co now owns 991 shares of the medical instruments supplier’s stock valued at $28,000 after acquiring an additional 644 shares during the last quarter. SJS Investment Consulting Inc. acquired a new stake in DENTSPLY SIRONA in the 3rd quarter valued at about $35,000. Van ECK Associates Corp acquired a new stake in DENTSPLY SIRONA in the 2nd quarter valued at about $41,000. Finally, Parkside Financial Bank & Trust lifted its holdings in DENTSPLY SIRONA by 163.7% in the 1st quarter. Parkside Financial Bank & Trust now owns 915 shares of the medical instruments supplier’s stock valued at $46,000 after acquiring an additional 568 shares during the last quarter. 98.52% of the stock is owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

A number of brokerages have weighed in on XRAY. Evercore ISI upped their price target on shares of DENTSPLY SIRONA to $34.00 in a report on Thursday, November 17th. Morgan Stanley reduced their price objective on shares of DENTSPLY SIRONA from $42.00 to $39.00 and set an “overweight” rating for the company in a research note on Tuesday, November 15th. TheStreet lowered shares of DENTSPLY SIRONA from a “c” rating to a “d” rating in a research note on Monday, November 14th. UBS Group reduced their price objective on shares of DENTSPLY SIRONA to $35.00 in a research note on Thursday, November 17th. Finally, Barrington Research reduced their price objective on shares of DENTSPLY SIRONA from $51.00 to $40.00 in a research note on Tuesday, November 15th. Seven analysts have rated the stock with a hold rating and three have given a buy rating to the company’s stock. According to data from MarketBeat, DENTSPLY SIRONA has a consensus rating of “Hold” and an average price target of $40.70.

DENTSPLY SIRONA Stock Performance

Shares of XRAY opened at $36.97 on Monday. DENTSPLY SIRONA Inc. has a fifty-two week low of $26.48 and a fifty-two week high of $58.70. The company has a current ratio of 1.50, a quick ratio of 1.04 and a debt-to-equity ratio of 0.48. The business’s 50-day moving average is $32.15 and its 200-day moving average is $32.37.

DENTSPLY SIRONA (NASDAQ:XRAYGet Rating) last released its quarterly earnings data on Monday, November 14th. The medical instruments supplier reported $0.41 EPS for the quarter, missing analysts’ consensus estimates of $0.59 by ($0.18). DENTSPLY SIRONA had a positive return on equity of 9.63% and a negative net margin of 20.81%. The firm had revenue of $947.00 million during the quarter, compared to analyst estimates of $1.01 billion. During the same quarter in the prior year, the company posted $0.68 EPS. The company’s quarterly revenue was down 8.9% on a year-over-year basis. On average, analysts anticipate that DENTSPLY SIRONA Inc. will post 1.96 EPS for the current fiscal year.

DENTSPLY SIRONA Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Friday, January 13th. Investors of record on Friday, December 30th were issued a $0.125 dividend. The ex-dividend date of this dividend was Thursday, December 29th. This represents a $0.50 dividend on an annualized basis and a yield of 1.35%.

DENTSPLY SIRONA Company Profile

(Get Rating)

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies for professional dental market worldwide. The company operates through two segments, Technologies & Equipment, and Consumables. The Technologies & Equipment segment provides dental equipment, such as treatment centers, imaging equipment, motorized dental handpieces, and other instruments for dental practitioners and specialists; dental CAD/CAM technologies for dental offices to support various digital dental procedures, including dental restorations; dentist-directed clear aligner solutions, SureSmile, and direct-to-consumer clear aligner solutions, as well as high frequency vibration technology device; implants; and urology catheters and other healthcare-related consumable products.

Featured Articles

Want to see what other hedge funds are holding XRAY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for DENTSPLY SIRONA Inc. (NASDAQ:XRAYGet Rating).

Institutional Ownership by Quarter for DENTSPLY SIRONA (NASDAQ:XRAY)

Receive News & Ratings for DENTSPLY SIRONA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA and related companies with MarketBeat.com's FREE daily email newsletter.